High-risk myeloma: a gene expression based risk-stratification model for newly diagnosed multiple myeloma treated with high-dose therapy is predictive of outcome in relapsed disease treated with single-agent bortezomib or high-dose dexamethasone. (Q42953783)
Jump to navigation
Jump to search
scientific article published on January 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | High-risk myeloma: a gene expression based risk-stratification model for newly diagnosed multiple myeloma treated with high-dose therapy is predictive of outcome in relapsed disease treated with single-agent bortezomib or high-dose dexamethasone. |
scientific article published on January 2008 |
Statements
High-risk myeloma: a gene expression based risk-stratification model for newly diagnosed multiple myeloma treated with high-dose therapy is predictive of outcome in relapsed disease treated with single-agent bortezomib or high-dose dexamethasone (English)
George Mulligan
John D Shaughnessy
Bart Barlogie
1 January 2008